Naloxone guidance document updated
February 15, 2017
As communicated in the Message from the Registrar circulated on February 7, Alberta Health amended the Scheduled Drugs Regulation to move “Naloxone and its salts for use in emergency treatment of opioid overdose outside of a hospital setting” from Schedule 2 to unscheduled.
The provincially funded Take Home Naloxone (THN) program remains unchanged. ACP’s guidance document for the provision of Naloxone kits as part of the provincial program has been updated to reflect the schedule change. Please note that ACP does not support the provision of injectable Naloxone outside of the provincial program.
ACP supports the government’s work in addressing the opioid crisis and we believe that pharmacists play an integral role in the delivery of care to Alberta’s vulnerable populations. If you have not already done so, we encourage you to complete the accredited training available through the Alberta Pharmacists’ Association website and to register to participate in the THN program.